secwatch.observer — SEC 8-K summary
======================================

Issuer:     Philip Morris International Inc. (PM)
CIK:        0001413329
Form:       8-K
Filed at:   2022-12-14T23:59:59+00:00
Accession:  0001413329-22-000137
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Philip Morris appoints Jorge Insuasty President of Vectura Fertin Pharma; adjusts de Wilde's compensation
--------------------------------------------------------------------------------

- Jorge Insuasty appointed full-time President, Vectura Fertin Pharma effective Jan 1, 2023; continues reporting to CEO Jacek Olczak.
- Insuasty steps down as Chief Life Sciences Officer; Badrul Chowdhury now reports directly to CEO as Chief Life Sciences Officer, Smoke-Free Products.
- Frederic de Wilde appointed President of SSEA, CIS, MEA region; base salary increased to CHF 1,000,008 (approx. $1,080,009).
- de Wilde's annual incentive target set at 125% of base salary; equity award target at 275% of base salary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1413329/000141332922000137/0001413329-22-000137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1413329/000141332922000137/pm-20221208.htm
  HTML page:      https://secwatch.observer/filing/0001413329-22-000137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer